Xavier Arnaud

Xavier Arnaud has over two decades of experience in corporate business development and strategic portfolio management within the pharmaceutical industry. Currently serving as the Director of Corporate Business Development at FAES FARMA since July 2016, Xavier focuses on growth through acquisitions and partnerships in the EU and emerging markets. Previous positions include Vice President roles at Fresenius Kabi and Mylan, where strategic portfolio development was key. Earlier in the career, Xavier held managerial roles at Sandoz and GNR-pharma, with significant accomplishments in product launches and marketing strategy. Education includes a doctorate in Pharmacy from Université Paul Sabatier and a DESS in Marketing from Université Toulouse 1 Capitole.